Adaptive Biotechnologies
ADPT----
Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Adaptive Biotechnologies Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$22.290.07%
Forecast & RatingBuy
8analysts
- Strong buy62.50%
- Buy25.00%
- Hold12.50%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 15 hours ago
The Market's Island of Misfit Toys: Who Is Actually Making Cash in 2026?
- Global Report · 15 hours ago
Tech and Biotech Overhauls Accelerate Amid 50% Revenue Surges
- PUBT · Jul 23 at 06:35 PM
Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million
- benzinga_article · Jul 21 at 10:14 AM
This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday
- PUBT · Jul 20 at 06:20 PM
Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000
- Simplywall · Jul 17 at 08:06 PM
Is Adaptive Biotechnologies (ADPT) Below Fair Value Or Too Pricey On Sales?
